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ABSTRACT 
 
The Grad uate School of Molecular Medicine combines systematic 
doctoral education of the highest quality to the best research 
expertise in molecu lar medicine at the A. I. Virtanen Institu te for 
Molecular Sciences and  Department of Medicine in the Facu lty of 
Health Sciences in the University of Eastern Finland . The doctoral 
students of the school work as active researchers in the 
participating research groups whose scientific activities belong to 
six research programs: Card iovascular Diseases, Type 2 Diabetes 
and  Card iovascular Diseases, Type 2 Diabetes and  Obesity , 
Neurodegenerative Diseases, Stem Cell Research, and  
Inflammatory States.  
 
This book compiles the abstracts of the 4th Annual Post-Graduate 
Symposium of the Graduate School of Molecular Medicine to be 
held  in Tahkovuori, Nilsiä, on March 16  17, 2010. 
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GRADUATE SCHOOL OF MOLECULAR MEDICINE 
WINTER SCHOOL 2010 
MARCH 16  17, TAHKOVUORI NILSIÄ 
 
PROGRAM 
 
Tuesday, March 16 
 
7:30   Departure from Bioteknia 1 (Neulaniementie 2) 
8:45  9:15 Coffee (TahkoSpa) 
Poster set up   
9:15  9:20 Opening of the Symposium , Seppo Ylä-Hert tuala  
(TahkoSpa, Multifunction Arena) 
 
9:20  10:55 ORAL SESSION I 
Chairs: Lili Li and Antti Kurronen 
 
9:20  9:40 	 
	 	 	 	 	 	   Heikki 
Tanila 
9:40  9:55 	  -associated  ubiquilin-1 regu lates presenilin-1 
accumulation and  aggresome formation  Jayashree Visw anathan 
9:55  10:10 	 	 	 	 	 	  	 	 	
selected  on the basis of the AlzGene database meta-analyses Timo 
Sarajärv i  
10:10  10:25 	  -associated  protein ubiqulin-1 regulates 
BACE1 translation through decreased  eIF-2-alpha 
phosphorylation in ER-stress Teemu Natunen 
10:25  10:40 Sodium channel blocking antiepileptic d rugs suppress 
spontaneous epileptiform d ischarges in APdE9 mouse model of 
Alzheimer's d isease Sofya Ziyatdinova  
10:40  10:55 Loss of hippocampal GABAergic interneurons d uring 
epileptogenesis: comparison of SE and  TBI as epileptogenic 
etiology Noora Huusko 
 
10.55  11.45 LUNCH & EXHIBITION (TahkoSpa) 
 
11:45  12:50 ORAL SESSION II 
Chairs: Miika Martikainen and Hanna Leskinen 
 
11:45  12:05 Tumor metastasis and  angiogenesis as well as novel therapy 
options Pirjo Laakkonen 
12:05  12:20 MDGI in cancer progression and  metastasis Kat ja Häkkinen 
12:20  12:35 15-LO-1 ind uced  apoptosis inhibits tumour growth and  extends 
survival in rat glioma mod el Agnieszka Pacholska 
12:35  12:50 Susceptibility to alphavirus-mediated  oncolysis of GL261 and  CT-
2A syngeneic mouse gliomas in vitro and  in vivo Janne 
Ruotsalainen 
 
12:50  13:00 BREAK 
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13:00  14:05  ORAL SESSION III 
Chairs: Suvi Jauhiainen and Anastasia Shakirzyanova 
 
13:00  13:15 Vascu lar endothelial growth factor (receptor) expression during 
ad ipocyte d ifferentiation in vitro Marike Dijkstra  
13:15  13:30 The role of VEGF-A /  PLC-gamma pathway in card iac myocytes 
Genet  Assefa 
13:30  13:50 A short story about migraine aura and  migraine pain Rashid 
Giniatullin 
13:50  14:05 Oxidative stress in migraine pain transduction Olga Kyry lenko  
 
14:05  15:05 COFFEE, POSTER SESSION & EXHIBIOTION  
 
15:05  16:25 ORAL SESSION IV 
Chairs: Teemu Laitinen and Dorota Kaminska 
 
15:05  15:20 Transgenic rat models Sigma-Aldrich 
15:20  15:40 MRI  a non-invasive tool for biomedical research  Olli Gröhn 
15:40  15:55 Implementation of pharmacological MRI Joanna Hut tunen 
15:55  16:10 Simultaneous BOLD fMRI and  local field  potential measurements 
of epileptic seizures in awake and  medetomid ine sedated  rats 
Antt i Airaksinen 
16:10  16:25 MRI detection of short T2 component in brain by SWIFT Lauri 
Lehto 
 
16:25  20:30 Check in 
Outdoor activities 
 
20:30   DINNER (SokosHotel Tahkovuori) 
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GRADUATE SCHOOL OF MOLECULAR MEDICINE 
WINTER SCHOOL 2010 
MARCH 16  17, TAHKOVUORI NILSIÄ 
 
PROGRAM 
 
Wednesday, March 17 
 
7:00  8:30 Breakfast (SokosHotel Tahkovuori) 
 
8:30  9:50 ORAL SESSION V 
Chairs: Kati Pulkkinen and Jagadish Vangipurapu 
 
8:30  8:50 Vascu lar and  metabolic effects of Nrf2 Anna-Liisa Levonen 
8:50  9:05 Nitro-fatty acids activate Nrf2 by Keap1 cysteine 151-independent 
mechanism Emilia Kansanen 
9:05  9:20 Antioxidant response element  regulated  vectors for cancer gene 
therapy Hanna Leinonen 
9:20  9:35 SUR1-E1506K knock-out mouse: a d isease model for impaired  
insu lin secretion and  type 2 d iabetes Maija Tusa  
9:35  9:50 Characterization of aP2-SSAT mouse line Taina Roiha 
 
9:50  10:00 BREAK 
 
10:00  11:20 ORAL SESSION VI 
Chairs: Sini Pirnes-Karhu and Mitja Kurki 
 
10:00  10:15 SIRT1 regulates TCF7L2 in pancreatic beta-cells and  ad ipocytes 
Shalem Raju Modi  
10:15  10:30 Association of 16 SNPs increasing fasting glucose level w ith 
ind ices of insulin release, proinsulin conversion, and  insulin 
sensitivity in 6,696 non-d iabetic Finnish men Alena Stanèáková  
10:30  10:45 Biod istribution of IGF-1 in transgenic CLN mice  a novel 
candid ate for the treatment of INCL Tuulia Huhtala  
10:45  11:00 Biofunctionalization of mesoporous silicon nanoparticles for 
targeted  peptide delivery Jussi Rytkönen 
11:00  11:20 Programming organogenesis: the kidney as a model system Seppo 
Vainio 
 
11:20  12:20 LUNCH & EXHIBITION (TahkoSpa) 
 
12:20  13:20 ORAL SESSION VII 
Chairs: Sara Paulo and Yuriy Pomeshchik 
 
12:15  12:35 Multifaceted  nature of inflammation in neurodegenerative 
d iseases Tarja Malm 
12:35  12:50 Role of NF-kappa-B p50 gene on behavior and  neuropathology of 
APP/ PS1 	 	 	 	 	  	
Lakshman Puli 
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12:50  13:05 Neuroinflammation  stem cell derived  neural progenitors and  
inflammatory response in a mouse model of cerebral stroke Kaisa 
Savolainen 
13:05  13:20 Novel beneficial properties of granulocyte colony stimulating 
factor treatment in mouse model of amyotrophic lateral sclerosis  
Eveliina Pollari  
 
13:20  13:30  BREAK 
 
13:30  14:15 ORAL SESSION VIII 
Chairs: Maykel Lopez Rodriguez and Juha-Pekka Niskanen 
 
13:30  13:45 Protein d isulphide isomerase regulates SOD1 activity and  controls 
cytochrome C-catalyzed  peroxidation  implications for 
mitochondrial ROS production in ALS models Merja Jaronen 
13:45  14:00 Characterization of the phagocytic capacity of bone marrow 
derived  monocytic cells towards A-beta Ekaterina Savchenko  
14:00  14:15 Organotypic slice culture in spinal cord  injury Susanna Boman 
 
14:15  14:45 COFFEE 
 
14:45  15:05 Awards committee 
Best presentations 
Director of the GSMM, Best doctoral thesis 2009 
Closing of the symposium  
 
15:05   Departure 
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GRADUATE SCHOOL OF MOLECULAR MEDICINE 
WINTER SCHOOL 2010 
MARCH 16  17, TAHKOVUORI NILSIÄ 
 
PROGRAM 
 
Posters: 
 
1. Creation of rtTA-shVEGF-A mice Riina Rissanen 
2. Mutant-SOD1 toxicity in BV2 microglial cells Sara Paulo 
3. fMRI based  detection of brain regions involved  in activation of trigeminal 
nociceptive system in migraine-like states Artem Shat illo 
4. Independent enrichment analysis of gene sets Mit ja Kurki  
5. A naturally occurring dominant-negative splice variant regulates the 
responsiveness of G-alphaq-regulated  rhoGTPase activators Lili Li 
6. Effects of CD36 inhibition in the outcome of cerebral ischemia  Hiramani 
Dhungana 
7. Alternative sp licing is regu lated  by weight loss and  d iffers between fat depots 
in humans Tiina Kuulasmaa 
8. Immunological characterization of sp ermid ine/ spermine-N1-acetyltransferase 
(SSAT) transgenic mice Sini Pirnes-Karhu 
9. Identification of genes involved  in short term and  long term hyperexcitable 
brain states Natalia Sherina 
10. Targeting MAPKKK as molecular therapeutic candidates for MAPK-related  
pathological conditions Maykel Lopez  Rodriguez  
11. VEGF-B167 over expression card iac hypertrophy and  exercise Anniina 
Muhonen 
12. Evaluation of functional d eficit and  recovery in the rat somatosensory cortex 
after moderate traumatic brain injury Juha-Pekka Niskanen 
13. Impact of A-beta conformers on hippocampal and  cortical cell activity Dorota 
Kaminska  
14. Kimmo Nikkanen (BCO)  
11 
 
 
 
 
Oral Session I 
Chairs: 
 Lili Li & Antti Kurronen   
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A	
 DISEASE-ASSOCIATED UBIQUILIN-1 REGULATES 
PRESENILIN-1 ACCUMULATION AND AGGRESOME FORMATION  
Jayashree Viswanathan, Annakaisa Haapasalo, Claudia Böttcher, Riitta Miettinen, Kaisa Kurkinen, 
Christa Maynard, Alice Lu, Lars Bertram, Hilkka Soininen, Rudolph Tanzi, Nico Dantuma and 
Mikko Hiltunen 
Institute of Clinical Medicine - Neurology, University of Eastern Finland, Kuopio. 
Ubiquilin-1 is a ubiqu itin-like protein genetically and  functionally associated  to 
Alzheimer's d isease (AD). It mediates proteasomal degrad ation of proteins 
includ ing AD-associated  presenilin-1 (PS1) and  causes PS1 accumulation. Here we 
characterized  the effects of d ifferent ubiquilin -1 transcript variants (TV), full-
length TV1 and  the proteasome-interaction domain lacking TV3, on PS1 
accumulation and  ubiquitin -proteasome system (UPS).  TV1 or TV3 and  PS1 
cDNAs were transiently transfected  to human embryonic kid ney cells 
overexpressing APP (HEK293-AP-APP). The effects were assessed  by Western 
blotting, fluorescence and  electron microscop y (EM) and  ELISA. Co-expression of 
especially TV3 with PS1 induced  the accumulation and  stabilization of PS1, effects 
not caused  by a general impairment of UPS. Accumulated  PS1 co -localized  with 
TV1 and  TV3 in juxtanuclear aggresomes in both HEK293-AP-APP and  cortical 
cells. EM confirmed  the presence of TV1 and  TV3 in aggresomes and  
autophagosomes. PS1 accumulation and  aggresome formation coincided  with 
decreased  production of A-beta, particu larly in TV3-expressing cells. Our results 
suggest that specific u biquilin-1 TVs regu late PS1 accumulation and  targeting into 
the aggresome-autophagosome pathway reducing the available PS1 for gamma-
secretase complex hence reducing A-beta production. 
 
	
	
SELECTED ON THE BASIS OF THE ALZGENE DATABASE META-
ANALYSES 
Timo Sarajärvi, Seppo Helisalmi, Leila Antikainen, Petra Mäkinen, Anne Maria Koivisto, Annakaisa 
Haapasalo, Hilkka Soininen, Mikko Hiltunen 
Institute of Clinical Medicine  Neurology, University of Eastern Finland and Department of Neurology, Kuopio 
University Hospital, Kuopio, Finland. 
	 	!"#				$	 		
	
ind ividual susceptibility genes with low risk effects. In order to assess the risk 
gene profile among Finnish AD patients, we selected  22 most promising candid ate 
genes on the basis of the meta-analyses retrieved  from the AlzGene database. 
Single nucleotide polymorphisms (SNP) from 22 genes were genotyped  from 647 
Finnish AD patients and  687 cognitively healthy controls using Sequenom 
platform. Subsequently, logistic regression and  Kaplan -Meier analyses were 
performed to assess single SNP effects on the AD risk and  the age of onset. SNP 
data were also correlated  to cerebrospinal fluid  (CSF) A-beta-42, total tau and  
phosphorylated  tau levels in AD patients. A statistically significant genotype and  
allele association with AD was observed  with rs1800529 in the TNF-alpha gene 
(p<0.05). APOE, gender and  age-ad justed  logistic regression analysis revealed  a 
protective effect for A allele carriers of rs1800529 (p=0.02: OR=0.69, 95% CI 0.49-
0.95). Also, AD patients carrying the minor allele of rs600879 in SORCS1 showed a 
statistically significant increase in CSF A-beta-42 levels (p<0.05), whereas 
rs1143634 allele in IL1B associated  with increased  phosphorylated  tau levels in the 
CSF (p<0.05). These find ings suggest that rs1800529 in the TNF-alpha gene 
encompasses a protective effect among Finnish  AD patients. 
13 
 
ALZHE	
 -ASSOCIATED PROTEIN UBIQUILIN -1 
REGULATES BACE1 TRANSLATION THROUGH DECREASED EIF2-ALPHA 
PHOSPHORYLATION IN ER-STRESS  
Teemu Natunen, Kaisa Kurkinen, Jayashree Viswanathan, Petra Mäkinen, Hilkka Soininen, 
Annakaisa Haapasalo, Mikko Hiltunen 
Institute of Clinical Medicine  Neurology, University of Eastern Finland and Department of Neurology, Kuopio 
University Hospital, Kuopio, Finland. 
Endoplasmic reticulum (ER) stress plays an important role in the pathogenesis of 
A	 	!"#	&	
	
			
 -expression of the 
AD-associated  protein, ubiquilin -1 alleviates pro-apoptotic C/ EBP homologous 
protein (CHOP) induction during ER-stress and  increases cell viability. 
Interestingly, phosphorylation of Ser51 site in the translation initiation factor eIF2-
alpha has been shown to correlate with beta-secretase (BACE1) levels in d ifferent 
stress conditions. Here we have assessed  whether ubiqu ilin -1 regulates BACE1 
translation through eIF2-alpha phoshorylation in ER-stress. To address changes in 
*+>	?	*+>	"@						J-UTR 
were transfected  into human neuroglioma H4 cells stably over -expressing 
ubiquilin-1. ER-stress was induced  using tunicamycin and  protein lysates were 
analyzed  by Western blotting. Over-expression of ubiquilin-1 decreased  Ser51 
phosphorylation of eIF2-alpha on average by 40% after 5-hour tunicamycin 
treatment when compared  to naïve cells. Decreased  eIF2-alpha phoshorylation 
status in turn correlated  with reduced  BACE1 levels in ubiquilin -1 over-expressing 
H4 cells. These find ings suggest that ubiquilin -1 regulates BACE1 translation 
through eIF2-alpha phosphorylation in ER-stress.   
 
SODIUM CHANNEL BLOCKING ANTIEPILEPTIC DRUGS SUPPRESS 
SPONTANEOUS EPILEPTIFORM DISCHARGES IN APDE9 MOUSE MODEL 
	
 
Sofya Z iyatdinova[1], Kestutis Gurevicius[1], Tamuna Bolkvadze[1], Heikki Tanila[1,2], Asla 
Pitkänen[1,2] 
[1] Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 
Kuopio, [2] Department of Neurology, Kuopio University Hospital, Kuopio, Finland. 
	  	 !"#	 	 
	 	 	 	 	 
	 	
seizures as compare with general population. Spontaneous seizures and  frequent 
epileptiform d ischarges (EDs) are reported  in mouse models of AD with increased  
amyloid  beta peptide production. Sodium channels deficiency in GABAergic 
interneurons has been proposed  to contribu te to hyperexcitability. This gave rise  
to hypothesis that d rugs blocking sod ium channels might exacerbate spontaneous 
seizures or EDs.  We aimed  to study the effect of common used  sod ium channel 
blocking antiepileptic d rugs (AEDs) on spontaneous seizures or EDs in APd E9 
mice. 12-13 wk old  APdE9 mice were successively treated  with vehicle, followed  
by CBZ (10 mg/ kg, t.i.d .), DPH (10 mg/ kg, t.i.d .), or VPA (260 mg/ kg, b.i.d .) for 3 
d . After wash-out and  new vehicle treatment, higher doses of CBZ (40 mg/ kg, 
t.i.d .), DPH (40 mg/ kg, t.i.d .), or VPA (400 mg/ kg, b.i.d .) were administered  for 5 
d . During the experiment, mice were under continuous (24/ 7) video-EEG 
monitoring. Each treatment reduced  the number of spontaneous electrographic 
EDs. VPA was the most effective by reducing the ED frequency below  50% of that 
at baseline in 75% of mice. No exacerbation of spontaneous seizures or EDs was 
seen even at AED doses close to TD50. 
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LOSS OF HIPPOCAMPAL GABAERGIC INTERNEURONS DURING 
EPILEPTOGENESIS: COMPARISON OF SE AND TBI AS EPILEPTOGENIC 
ETIOLOGY  
Noora Huusko, Christine Römer, Asla Pitkänen 
Epilepsy Research Laboratory, Department of Neurobiology, A.I. Virtanen Institute for Molecular Science, 
University of Eastern Finland, Kuopio. 
Brain insults can trigger ep ileptogenic process which after a latency pha se leads to 
the development of spontaneous seizures and  epilepsy. In ad ult brain, the changes 
in GABAergic network in post-injury hippocampus can play a major role in 
epileptogenesis. Two models of temporal lobe epilepsy were used , one induced  by 
traumatic brain injury (TBI) and  another with status epilepticus (SE). After 7 
months both SE and  TBI animals were video-EEG monitored  to detect 
spontaneous seizures. TBI rats were also tested  in pentylenetetrazol seizure 
threshold  test. Brains were processed  for immunohistochemical analysis of 
GABAergic neurons (NPY, PARV, CR, CCK, SOM). After TBI, there was a 
decrease in the number of all d ifferent types of GABAergic neurons in the hilus 
(p<0.05). These rats had  no spontaneous seizures during video-EEG monitoring 
but seizure threshold  was lowered . Only NPY and  PARV-ir neurons were reduced 
after SE (p<0.05). Interestingly, these rats had  spontaneous seizures. These 
observations suggest that reduced  perisomatic inhibition in the dentate gyrus can 
contribute to seizure susceptibility. However, even a d ramatic loss in hilar 
inhibitory neurons is not necessarily associated  with occurrence of spontaneous 
seizures. 
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Oral Session II 
Chairs: 
 Miika Martikainen & Hanna Leskinen   
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MDGI IN CANCER PROGRESSION AND METASTASIS 
Katja Häkkinen[1], Johanna Lammi[2], Kirsi Vuorinen[1], Outi Rautsi[1], Pirjo Laakkonen[1,2] 
[1] A. I. V . Institute, Department of Biotechnology & Molecular Medicine, University of Eastern Finland, 
Kuopio, [2] Molecular Cancer Biology Research Program & Institute of Biomedicine, University of Helsinki. 
We have recently identified  a novel peptide that homes and  binds specifically to 
malignant brain tumors. Mammary derived  growth inhibitor (MDGI) was 
identified  as the receptor molecule for our pept ide. MDGI belongs to the family of 
fatty acid  bind ing proteins and  it is the only FABP that affects cell proliferation. 
FABPs reside normally in the cytoplasm. However, in tumors MDGI is found  
outside of the cells and  associated  with the tumor vasculature  where it is 
accessible to circulatory ligand s. The role of MDGI in tumor genesis is 
controversial. In order to study the functional role of MDGI in tumor progression 
and  metastatic spread  we created  stable MDA-MB-231 human breast carcinoma 
cell lines expressing MDGI. The parental MDA-MB-231 cells express MDGI at very 
low level. In the current study we compared  the growth and  metastatic spread  of 
MDGI-MDA and  the parental MDA-MB-231 subcutaneous tumors in Balb/ c/ Sca-
nu/ nu mice. Preliminary data from the growth curves of the xenograft tumors 
show that tumors with high MDGI expression grow slower than the parental 
tumors. The analysis of the reasons for the growth d ifference and  metastatic 
potential of these tumors is ongoing. Our results w ill provide new info rmation 
about the role of MDGI in cancer progression and  metastasis. 
 
15-LO-1 INDUCED APOPTOSIS INHIBITS TUMOUR GROWTH AND 
EXTENDS SURVIVAL IN RAT GLIOMA MODEL 
Agnieszka Pacholska, Helena Viita, Farizan Ahmad, Essi Uusitalo, Anna Hyvärinen, Thomas Wirth 
and Seppo Ylä-Herttuala 
Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences. 
Gliomas are among the most vascu larised  tumours in humans, what makes them a 
very promising target for anti-angiogenic therap ies. It is known that 15-LO-1 may 
possess strong anti-angiogenic properties. We have proved  that it as well induces 
apoptosis by induction of lip id  peroxid ation in vivo. Therefore, we concluded  that 
15-LO-1 gene therapy could  be used  as a promising cancer treatm ent acting 
through two independent mechanisms with pro-apoptotic therapeutic effects 
add itionally being complemented  by inhibition of tumour angiogenesis. BDIX 
male rats were injected  with 104 BT4C glioma cells into the right corpus callosum. 
The rats were d ivided  into two cohorts: group I, which received  adenoviral vector 
carrying 15-LO-1 transgene and  group II, which was a control group. Tumour 
growth was verified  14 days after cell injection by magnetic resonance imaging 
(MRI). On the consecutive day animals received  3 injections of Adh15-LO-1, 
followed by two additional ones applied  the next d ay. We have shown that 15-LO-
1 delayed  tumour growth and  extended  survival by 18 % in rat malignant glioma 
model. Those resu lts support the pro-apoptotic role of 15-LO-1 and  prove that it 
could  be a potential new treatment gene for the therapy of malignant glioma. 
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SUSCEPTIBILITY TO ALPHAVIRUS-MEDIATED ONCOLYSIS OF GL261 
AND CT-2A SYNGENEIC MOUSE GLIOMAS IN VITRO AND IN VIVO  
Janne Ruotsalainen[1], Miika Martikainen[1], Tytti Aaltonen[2], Jari Heikkilä[2], Markus Vähä-
Koskela[3], Ari Hinkkanen[1] 
[1] A. I. Virtanen Institute for Molecular Medicine, University of Eastern Finland, Kuopio,  
[2] Department of Biochemistry, Åbo Akademi, Turku, Finland, [3] Ottawa Health Research Institute, Canada. 
Semliki Forest virus derived  vector VA7 effectively infects and  kills a number of 
human and  murine tumor cells in vitro and  in vivo when implanted  in immune 
compromised  mice. Cell cultures of syngeneic glioma (GL261) and  astrocytoma 
(CT2A) were established  and  VA7-EGFP infectivity and  innate immune responses 
were analyzed  with fluorescence microscopy and  Western blotting respectively. 
For in vivo stud ies GL261 cells were injected  intracranially into the caud ate 
putamen of immunocompetent C57BL/ 6 mice and  after the tumors had  
developed , 10>6 pfu of VA7 vector was injected  via tail vein. Both cell lines were 
infected  by VA7 in culture and  70% and  95% lysis was reached  after 72 hrs p .i. for 
CT-2A and  GL261 cells, respectively. Infection with VA7 of GL261 cell line 
resulted  in expression of antiviral oligoadenylate synthase (OAS) active (40 kDa) 
form, whereas PKR and  eIF-2a levels remained  unchanged . In the pilot in vivo 
stud ies, none of the treated  mice survived  even when immunosuppsessed  with 
CPA. We conclude that innate immune responses includ ing interferon -related  
factors expressed  in tumor cells upon infection with VA7 pose hurd les to vector 
replication and  oncolytic efficacy. Alternative approaches to evade the 
immunoresponse are needed . 
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VASCULAR ENDOTHELIAL GROWTH FACTOR (RECEPTOR) EXPRESSION 
DURING ADIPOCYTE DIFFERENTIATION IN VITRO 
Marike Dijkstra, Eija Pirinen, Seppo Ylä-Herttuala 
Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, 
University of Eastern Finland, Kuopio. 
Adipogenesis is tightly associated  with angiogenesis. VEGF-A accounts for most 
of the angiogenic activity of ad ipose tissue. VEGF-A is an angiogenic factor 
expressed  in and  secreted  by ad ipocytes in vivo and  in vitro. The expression 
pattern of the VEGF receptors and  the other VEGF family members have not been 
investigated  fully and  their role in ad ipocyte d ifferentiation in vivo and  in vitro is 
still unclear. Therefore, the aim of this study was investigate the expression 
pattern of VEGF(R)s in d ifferentiated  ad ipocytes in vitro. 3T3-L1 mouse fibroblasts 
were d ifferentiated  into ad ipocytes following stand ard  protocol. Messenger RNA 
levels of VEGF-A, VEGF-B, VEGF Receptor-1(VEGFR1), VEGFR2 and  neuropilin -1 
(nrp1) and  nrp2 were analyzed  at d ifferent time points using Taqman RT-PCR. 
Adipocyte d ifferentiation was confirmed  by Oil Red  O staining and  increased  
mRNA expression of PPAR-gamma and  CEBP-alpha. During ad ipocyte 
d ifferentiation, expression of VEGF-A, VEGF-B, and  nrp1 were increased  while 
VEGFR1 and  nrp2 mRNA levels decreased . No VEGFR2 mRNA was detected . 
These results suggest that the main role for VEGF-A in ad ipose tissue is activation 
of endothelial cells as VEGFR2 is exclusively expressed  in endothelial cells in 
ad ipose tissue. In add ition, the switch in expression levels of the VEGF-B bind ing 
receptors VEGFR1 and  nrp1 in ad ipocytes implies d ifferent signaling pathways 
induced  by VEGF-B in lipid  loaded  compared  to non-d ifferentiated  ad ipocytes. 
 
THE ROLE OF VEGF-A / PLC-GAMMA PATHWAY IN CARDIAC 
MYOCYTES 
Genet S. Assefa, Marike H. Dijkstra, Hanna Leskinen and Pasi Tavi 
Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, 
University of Eastern Finland, Kuopio. 
Vascu lar end othelial growth factor A (VEGF-A) is a potent angiogenic factor. In 
endothelial cells the signaling of VEGF-A is mediated  by two tyrosine kinase 
receptors, VEGFR-1 & -2. VEGF-A activates phospholipase C-gamma (PLC-
gamma) lead ing to formation of inositol 1, 4, 5 -trisphosphate (IP3) and  
d iacylglycerol (DAG). The IP3 increases cytosolic Ca2+, whereas DAG activates 
protein kinase C (PKC) pathway. PLC-gamma/ PKC-pathway is know n regulator 
of card iomyocyte contractility. Aim of the study is to characterize the effects of 
VEGF-A on PKC and  Ca signaling in card iac myocytes. Neonatal mouse or rat 
card iomyocytes were incubated  with VEGF-A164 in concentrations of 0, 5, 25 or 
100 ng/ ml for 48 h. RNA was extracted  for quantitative RT-PCR and  cytosolic and  
membrane fraction of proteins was extracted  for Western blotting. VEGF-A164 
dose-dependently increased  expression of VEGFR-1 & -2 in card iac myocytes 
(n=4/ group). VEGF-A164 (25 ng/ ml) induced  VEGFR-1 expression to 2.1-fold  
(p<0.05) and  VEGFR-2 expression to 5.2-fold  (p<0.01). Translocation of PKC-e and  
PKC-d  from cytosolic fraction to membrane fraction increased  to 3.0-fold  (p<0.01) 
and  2.2-fold  (p=0.05) in VEGF-A164 (25 ng/ ml) treated  cells (n=3 / group), 
whereas no change in PKC-a translocation was seen. In conclusion, our data show 
that VEGF-A164 up regulates the expression of VEGF receptors and  activates PKC 
signaling in card iac myocytes suggesting a potential role for VEGFs in the 
regulation of card iomyocyte contractility. 
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OXIDATIVE STRESS IN MIGRAINE PAIN TRANSDUCTION  
O. Kyrylenko, A . Shakirzyanova, R. Giniatullina,, N. Naumenko, G. Bart, D. Fayuk, K. Kanninen, J. 
Koistinaho, R. Giniatullin 
Department of Neurobiology, A.I.Virtanen Institute, University of Eastern Finland. 
Migraine is a type of chronic pain associated  with oxidative stress but whether 
pain transduction in migraine is affected  by reactive oxygen species (ROS) is 
unknown. In this study, using patch clamp and  Ca2+ imaging technique, together 
with various biochemical approaches (NAD and  FOX1 assays), we tested  the role 
of ROS on expression and  function of pain transd ucing ATP-gated  P2X3 and  
capsaicin-activated  TRPV1 receptors of rat trigeminal neurons. Application of 
hydrogen peroxide for 5 h to cultured  trigeminal neurons increased  expression 
and  activity of TRPV1 receptor, whereas expression and  function of P2X3 receptor 
was not affected . We also observed  a d ramatic decrease of NAD+ in peroxide -
treated  cells. Interestingly, in Nrf2 knock-out mice, with compromised  antioxid ant 
defense, we found  decreased  expression and  activity of TRPV1 receptor along 
with increased  expression of P2X3 receptor, with no changes in NAD+ level. These 
data ind icate high plasticity of pain tran sducers associated  with d ifferent profile of 
ROS and  the level of intracellular NAD. 
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IMPLEMENTATION OF PHARMACOLOGICAL MRI 
Joanna Huttunen[1], Antti Airaksinen[1], Juha-Pekka Niskanen[1], Kimmo Lehtimäki[2], Olli 
Gröhn[1] 
[1] Department of Neurobiology, A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 
Kuopio [2] Cerebricon Ltd., Finland. 
Pharmacological magnetic resonance imaging (phMRI) is a novel MRI method  
where the pharmacological agent causes local activation or deactivation in the 
brain and  the sequential changes in the cerebral blood  flow, volume and  
oxygenation can be measured  with BOLD contrast. The aim of this work was to 
implement a robust approach to pharmacological MRI. Nicotine (n=4, 0.25-0.5 
mg/ kg, i.v.) caused  large cortical activation in freely breathing animals und er 
urethane anesthesia. Donepezil (n=9, 3 mg/ kg, s.c.), which is an acetyl 
cholinesterase inhibitor, induced  also muscle twitching and  hence a huge motion 
artifact to the MR images. Ventilation of the animals and  a dosage of muscle 
relaxant (pancuronium bromide, 0.5 mg/ kg/ h, i.v.) abolished  all motion artifacts 
but had  interaction with d onepezil. Therefore the effects of apomorfine (n=3, 0.25 
mg/ kg, s.c.), which is a d opamine receptor agonist, was also investigated . The 
selection of anesthetics, muscle relaxants and  pharmacological agents is important 
and  should  be carefully considered  to avoid  any undesirable interaction e ffects. 
Despite that, pharmacological MRI offers unique, non -invasive view to stud y 
pharmacokinetics, receptor activity and  drug actions in  normal and  pathological 
brain. 
 
SIMULTANEOUS BOLD FMRI AND LOCAL FIELD POTENTIAL 
MEASUREMENTS OF EPILEPTIC SEIZURES IN AWAKE AND 
MEDETOMIDINE SEDATED RATS 
Antti Airaksinen[1], S. Khan Hekmatyar[2], Neil Jerome[2], Juha-Pekka Niskanen[1,3], Asla 
Pitkänen [4,5], Risto Kauppinen[2], Olli Gröhn[1] 
[1] A.I.V., UEF, [2] Biomedical NMR Research Center, Dartmouth Medical School, USA,  
[3] Department of Physics and Mathematics, UEF, [4] Epilepsy Research Laboratory, A.I.V., UEF,  
[5] Department of Neurology, KUH. 
In the present study, we focused  on the effects of medetomid ine (domitor) 
sedation on simultaneous local field  potential (LFP)/ fMRI variables. First, we 
determined  the baseline cerebral blood  flow (CBF) in awake and  anesthetized  
(domitor and  isoflurane) rats. Second , simultaneous LFP/ fMRI measurements 
were performed  to compare BOLD signal changes, caused  by kainic acid  (KA) 
induced  epileptic seizures in awake and  domitor sedated  rats. CBF was stud ied  
using CASL technique. fMRI data were acquired  using EPI sequence. After KA 
injection (i.p ., 10 mg/ kg), image acquisition was continued  for 1.5 hours for each 
rat. The highest CBF values were observed  in isoflurane anesthetized  rats, the 
lowest ones were detected  in domitor sed ated  animals. After KA injection in 
awake and  domitor sed ated  rats, the LFP d ata showed epileptic seizures in the 
hippocampus. During this period , there w ere strong bilateral BOLD signal 
changes in the hippocampus. In all rats, positive signal increases in EPI time 
courses were observed  coincide with the observed  seizures in LFP signal. We 
conclude that domitor sedation is well su ited  for stud ies of the nor mal and  
pathologic rat brain, but a basal CBF level that is lower than that of awake rats 
should  be taken into account when interpreting the fMRI results. 
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MRI DETECTION OF SHORT T2 COMPONENT IN BRAIN BY SWIFT 
Lauri Lehto [1], Djaudat Idiyatullin [2], Curtis Corum [2], Michael Garwood [2], Olli Gröhn [1] 
[1] A. I. Virtanen Institute for Molecular Sciences, University of Kuopio, [2]; Center for Magnetic Resonance 
Research, University of Minnesota. 
Tissue components such as lip ids in cell membranes are likely to have very short 
transverse relaxation times, T2, making their detection practically impossible with 
conventional MRI methods. SWIFT is an imaging technique capable of detecting 
them, but since virtually the whole spectrum of signals w ith d ifferent ^	 	
detected , short T2 components are overpowered  by the long T2 components. In 
this study, two simple long T2 suppression methods combined  with SWIFT were 
investigated . Additionally, an alternative to suppression is introduced . First 
method  was based  on the idea that short T2 components d o not follow long pulses 
since their relaxation rate exceeds the excitation rate of the pulse. The preparation 
consisted  of an ad iabatic inversion followed  by a delay. Two d ifferent pulse 
lengths were compared . The second  method  was based  on a subtraction of a 
normal and  a short T2 suppressed  image. An ex vivo mouse brain was used  as a 
sample. All methods highlighted  the white matter tracts. The subtraction method  
had  a considerably higher SNR than the long pu lse method . Using the first 
method , suppression was higher with a shorter pulse. Results give promise that 
short T2 components can be highlighted  in SWIFT with d ifferent long T2 
suppression methods. 
 
  
26 
 
  
27 
 
 
 
 
Poster Session 
  
28 
 
CREATION OF RTTA-SHVEGF-A MICE  
Riina Rissanen, Mari Merentie, Line Lottonen, Jonna Koponen, Marike Dijkstra, Emilia Kansanen, 
Roseanne Girnary, Mikko Turunen, Seppo Ylä-Herttuala. 
Department of Biotechnology and Molecular Medicine, University of Eastern Finland 
It is known that the inhibition  of VEGF-A induces for example hypertension, 
proteinuria and  renal endothelial dysfunction. In humans VEGF-A antibod y 
Avastin, that is used  in anticancer therapy, also causes severe thromboembolic 
complications in up to 5 % of treated  patients. Therefore, we wanted  to stud y how 
much VEGF-A levels can be down-regulated  without severe side effects. For these 
purposes, lentiviral vector with doxycyclin inducible shRNA silencing VEGF-A 
via RNAi was created .  Functionality of the vector was tested  in our laborat ory 
and  the in vitro resu lts show efficient and  doxycyclin dose dependent manner of 
VEGF-A silencing. Also d oxycyclin induced  positive feedback loop was observed . 
By using this vector we have further created  a mouse strain via lentiviral 
transgenesis. Copynumber analysis done with southern blotting revealed  that 
most of the founder mice had  only few transgene copies in their genome. The mice 
have been bred  further successfully. In the future we will characterize the mouse 
strain and  the in vivo functionality of our viral construct in more detail. We will 
study the effects of VEGF-A down-regulation in d ifferent tissues by ultrasound  
and  immunohistological methods.  
 
MUTANT-SOD1 TOXICITY IN BV2 MICROGLIAL CELLS 
Sara Paulo, Gundars Goldsteins, Jari Koistinaho 
Unit of Neurobiology, A.I. Virtanen Institute for Molecular Sciences and Biocenter Kuopio, University of 
Eastern Finland, Kuopio. 
Mutations in Cu,Zn superoxide d ismutase (SOD1) causes familial amyotrophic 
lateral sclerosis (ALS). ALS is a non-cell-autonomous d isease, where mutant SOD1 
expression in microglia has been suggested  to contribute to degeneration of motor 
neurons.  Here, we stud ied  whether expression of various mutant SOD1s in 
microglial BV2 cell line is toxic and  alters nitric oxid e (NO) production in these 
cells. Some antioxid ative compound s were tested  regard ing their ability to rescue 
the cells. BV2 microglial cells were transfected  with SOD1 d imers (G37R-G37R, 
G37R-WT, G85R-G85R, G85R-WT and  WT-WT). After 24 h transfection western 
blot was used  to assess the transgene expression. Cell survival after transfection 
was determined  with a resazurin assay and  NO-release was measured  using 
Griess reagent. Catalase, ebselen, minocycline and  apocynin were applied  for the 
duration of transfection. We found  that G37R-G37R-SOD1 was the most toxic to 
BV2 cells, resulting in a loss of about 40 % viable cells compared  to non -transfected 
cells and  loss of 24 % compared  to WT-WT-transfected  cells after 24 h transfection. 
Minocycline reduced  G37R-G37R-SOD1 toxicity and  had  a tendency to suppress 
NO-release. Apocynin suppresed  NO-production but d id  not inhibit the toxicity. 
We conclude that G37R-G37R-SOD1-toxicity to BV2 cells is not attributable to 
increased  NO-production and  that minocycline protects microglial ce lls from this 
toxicity. 
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FMRI BASED DETECTION OF BRAIN REGIONS INVOLVED IN 
ACTIVATION OF TRIGEMINAL NOCICEPTIVE SYSTEM IN MIGRAINE-
LIKE STATES 
Artem Shatillo, Rashid Giniatullin, Olli Gröhn 
Department of Neurobiology, University of Eastern Finland 
Migraine is the most common neurological d isease but, paradoxically, the 
mechanism of persisting pain in migraine remains unknown. We plan to stud y 
brain processing of sensory inputs induced  by activation of trigeminal nociceptive 
system, utilizing its unique property to express tetrodotoxin (TTX) insensitive 
sod ium channels. Stimulating sensory neurons innervating whiskers pad  of Wistar 
rats in the presence of TTX and  register using fMRI change of central presentation 
of peripheral nociception. After urethane anesthesia stimulatory and  record ing 
electrodes will be implemented  into the whiskers pad s and  brain respectively. Rats 
will obtain a sc injection of TTX in the area between stimulatory electrodes and  
then transferred  to 4.7 T or 9.4 T Varian horizonta l MRI system. Area for fMRI will 
be identified  electrophysiologically as active regions respond ing to electrical 
stimulation of whickers. We will use multislice spin -echo sequence (TR 2.5s, TE 
60ms, 256×256, FOV 5 cm) for anatomical images and  spin echo EPI sequence (TR 
2s, TE 60ms, 64x64, FOV 2.5x2.5cm2, slice thickness 1.5 mm, 5 slices) for fMRI. We 
aim to increase understand ing of the pathophysiological mechanism of the 
migraine pain and  develop  novel animal model which can provide a platform for 
pre-clinical d rug testing. 
 
INDEPENDENT ENRICHMENT ANALYSIS OF GENE SETS 
Mitja Kurki[1,2], Jussi Paananen[1,2], Markus Storvik[2,3], Juha Jääskeläinen[4], Mikael von und 
zu Fraunberg[4], Garry Wong[1,2], Petri Pehkonen[2] 
[1] Department of Neurobiology; A.I. Virtanen Institute for Molecular Sciences, [2] Department of Biosciences, 
[3] Department of Pharmacology and Toxicology, University of Eastern Finland, [4] Department of 
Neurosurgery, Kuopio University Hospital, Kuopio, Finland. 
Stand ard  enrichment analysis of d ifferentially expressed  (DE) genes obtained  from 
gene expression stud ies finds over-represented  annotations such as functions or 
pathways. However, DE genes often include multiple gene subsets associated  to 
d istinct annotations that may be overlooked  by stand ard  EA. We present a novel 
method  and  software tool TAFFEL that eases the analysis of DE genes by 
clustering the genes to groups that have similar biological functions or are co -
regulated  by common transcription factors (TFs). As major improvement  to 
previous methods TAFFEL performs Independent Enrichment Analysis (IEA), 
which finds functionally homogeneous gene clusters that enrich TFs and  gene 
clusters homogeneous in regulatory TFs that enrich functional annotations. This is 
used  as evaluation to find  relevant clusters for the user among several and  to 
d iscover the control between regulatory proteins and  functions in stud ied  
conditions. We show that TAFFEL can find  expected  and  novel results by testing it 
with gene expression d ata obtained  from hu man hepatocyte treated  with 
forskolin. Second ly, we present analysis of DE from comparison of ruptured  and  
unruptured  saccu lar cerebral artery aneurysm walls. The results show usefulness 
of our method  in analysis of such uncharacterized  conditions. 
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A NATURALLY OCCURRING DOMINANT-NEGATIVE SPLICE VARIANT 
REGULATES THE RESPONSIVENESS OF G-ALPHAQ-REGULATED 
RHOGTPASE ACTIVATORS 
Lili Li, Tim Church, Soila Tossavainen, Suvi Parviainen, Veronika Redai, Michael Courtney 
 
RhoGTPases have a powerful influence on cell behavior and  fate via regulation of 
transcription and  the cytoskeleton. Extracellular signals activate RhoGTPases via 
G protein coupled  receptors. This is mediated  via well stud ied  G-alpha-12/ 13-
regulated  GTPase activators and  poorly characterized  G-alphaq-regulated  
activators of the neuronally-enriched  p63-Kalirin-Trio family (PKT-GEFs) 
implicated  in schizophrenia and  other d iseases. We have identified  and  used  
molecular biological and  biochemical methods to characterize a novel PKT-GEF 
splice variant, x12. This variant is expressed  in several d ifferent cell types. x12 is 
not merely inactive as a Rho activator, lacking critical Dbl-homology residues, bu t 
it also acts as a d ominant negative inhibitor of PKT-GEFs. Deletion analysis 
reveals the region sufficient for inhibition, which we find  possesses an unexpected  
yet strong homophilic interaction which may be responsible for the inhibitory 
action of this variant. We propose a model whereby activation of PKT-GEFs 
renders them competent to interact in tran s with the inhibitory region of x12. The 
variant may selectively target the activated  PKT-GEF population, thereby 
sharpening the response curve to activation signals to one with a more all -or-none 
character. 
 
EFFECTS OF CD36 INHIBITION IN THE OUTCOME OF CEREBRAL 
ISCHEMIA 
Hiramani Dhungana, Tarja Malm, Jari Koistinaho 
Neurobiology Unit, A .I. Virtanen Institute, University of Eastern Finland, Kuopio. 
Cerebral ischemia is the lead ing cause of d isability and  death world wide and  
requires long term hosp italization. It is caused  by cessation of blood  flow to the 
brain resu lting in insufficient delivery of oxygen and  nutrients to neuronal tissues. 
Ischemic d amage initiates inflammatory process as a defence mechanism in an 
attempt to restore tissue homeostasis. However, in acute phase of stroke, 
inflammation contributes to the development of delayed  brain d amage. Therefore, 
it has been suggested  that anti-inflammatory treatment may be beneficial for 
stroke patients. Fatty acid  translocase, CD36, is a class B scavanger  receptor that 
induces inflammatory response by activating NF-kappa-B. Since CD36 has been 
shown to be specifically involved  in inflammatory reactions in ischemic brain, 
pharmacological inhibition of CD36 has been suggested  a potential treatment for 
stroke. In this study we inhibited  CD36 by using sulfosuccinimidyl oleate sod ium 
(SSO) to elucidate the role of CD36 in cerebral ischemia. Balbc mice underwent 
permanent midd le cerebral artery occlusion and  received  SSO at the doses of 
20mg/ kg intraperitoneally 1 hour after induction of ischemia. Ischemic cell death 
was determined  by 2,3,5-triphenyltetrazolium chloride (TTC) staining after 48h 
time point. Preliminary data from TTC staining suggest a protective role of SSO by 
reducing acute edema associated  with ischemia. Further stud ies will be carried  out 
to confirm the effect of SSO and  CD36 inhibition in ischemic d amage. 
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ALTERNATIVE SPLICING IS REGULATED BY WEIGHT LOSS AND 
DIFFERS BETWEEN FAT DEPOTS IN HUMANS 
Tiina Kuulasmaa[1], Jussi Paananen[1], Joshua Schroeder[2], Sari Grönlund[3], Matti 
Pääkkönen[3], Helena Gylling[4], Mary Elizabeth Patti[2], Jussi Pihlajamäki[1] 
[1] Department of Medicine, University of Eastern Finland, [2] Research Division, Joslin Diabetes Center, 
Harvard Medical School, Boston, [3] Department of Surgery, Kuopio University Hospital, [4] Department of 
Clinical Nutrition, University of Eastern Finland. 
Alternative splicing leads to several mRNA isoforms, and  often to multiple protein 
variants. Our overall aim is to study the contribution  of alternative splicing in type 
2 d iabetes (T2DM) and  obesity. We therefore utilized  Affymetrix Human Exon 1.0 
_^		  	 	`	 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	  	 *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examine the  effect of weight loss on splicing of T2DM candid ate gen es and  novel 
genes, using ad ipose tissue samples taken from 11 subjects prior to and  following 
gastric bypass surgery. Additionally, PCR-cap illary electrophoresis method  was 
developed  for efficient screening of alternative spliced  exons in candid ate genes.  
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of TCF7L2, in exon 9 of GIPR and  in exon 11 of INSR (all p<0.0001) Interestingly, 
we also observed  altered  splicing patterns  between subcutaneous and  visceral fat, 
includ i	^	 	|	 $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alternative spliced  genes in response to weight loss and  between subcutaneous 
and  visceral fat depots have been identified , and  results will be presented . We 
conclude that alternative splicing is regulated  by both environmental effects (e.g. 
weight loss) and  anatomical location of ad ipose depot. Together, our d ata suggest 
that non-coding SNPs in known T2DM genes may contribute to d isease risk by 
modifying alternative splicing of candid ate genes. 
 
IMMUNOLOGICAL CHARACTERIZATION OF SPERMIDINE/SPERMINE-
N1-ACETYLTRANSFERASE (SSAT) TRANSGENIC MICE 
Sini Pirnes-Karhu[1], Sisko Juutinen[1], Petri Mäkinen[1], Sohvi Hörkkö[2], Leena Alhonen[1], 
Anne Uimari[1] 
[1] A. I. Virtanen Institute, Biotechnology and Molecular Medicine, Biocenter Kuopio, University of Eastern 
Finland, [2] Department of M icrobiology, University of Oulu 
Polyamines are small cationic molecules essential for many cellular processes, 
includ ing cell growth and  d ifferentiation. The mice over-expressing 
spermid ine/ spermine-N1-acetyltransferase (SSAT), a catabolic regu lator of 
polyamines, have several phenotypic and  metabolic changes when compared  with 
their non-transgenic littermates. The immunological features of these mice w ere 
investigated  for instance by histology, blood  count, leukocyte FACS analyses, 
immunoglobulin measurements and  haematopoietic stem cell transp lantation. The 
SSAT over-expressing mice exhibited  enlarged  second ary lymphoid  tissues, 
elevated  amount of leukocytes in blood  and  bone marrow and  the relative 
proportions of T, B, CD4+, CD8+ and  Treg cells were altered  in blood  and  spleen. 
In add ition, the relative proportion of IgG was altered  in blood . The changes in 
leukocyte populations seemed to originate from SSAT over-expression in the 
haematopoietic stem and / or progenitor cells, as demonstrated  by the bone 
marrow transplantation. The characterization of the d isturbed  haematopoiesis in 
the SSAT over-expressing mice will give new information about the role of 
polyamines and  their metabolism in cell proliferation  and  d ifferentiation 
processes. 
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IDENTIFICATION OF GENES INVOLVED IN SHORT TERM AND LONG 
TERM HYPEREXCITABLE BRAIN STATES 
Natalia Sherina, Rashid Giniatullin, Garry Wong 
Department of Neurobiology, University of Eastern Finland. 
The transcriptional response to cortical spread ing depression (CSD) is crucial for 
understand ing mechanisms responsible for migraine with aura. CSD is potentially 
able to induce multiple plastic changes includ ing gene transcription. A certain  
number of genes are up -regulated  in response to CSD (for example, COX-2, TNF-
a, IL-beta;, iNOS). Nonetheless, a comprehensive evaluation of multiple genes 
activated  in animal models of migraine is not yet available. The aim of this study is 
to uncover transcriptional responses following induction of migraine -like states in 
rats. These states will be induced  in rats by i.p . injection of nitroglycerin, i.p . 
injection of LPS, after CSD, and  by combination of these factors. mRNA from 
cortex, trigeminal ganglia and  meninges will be used  to identify a large cohort of 
genes activated  in migraine states on Microarray chips. The polymerase chain 
reaction in real time will be used  to valid ate the expression profile of d ifferentially 
expressed  genes involved  in various cellular events w ith stress on those which are 
involved  in pain transduction. This project should  provide a comprehensive view 
on multiple genes activated  in the cortex, trigeminal ganglia and  provide further 
explanation of the pathophysiological mechanisms of migraine-like states. 
 
TARGETING MAPKKK AS MOLECULAR THERAPEUTIC CANDIDATES 
FOR MAPK-RELATED PATHOLOGICAL CONDITIONS 
Maykel Lopez Rodriguez, Michael Courtney 
A.I. Virtanen Institute, Dpt. of Neurobiology. University of Eastern Finland, Kuopio. 
Mitogen Activated  Protein Kinases (MAPK) signalling pathways p lay key roles in 
both normal and  aberrant physiology. Despite the extensive find ings about the 
roles of MAPK in pathological cond itions, it is poorly understood  how - under 
which conditions a specific MAPKKK (upstream MAPK activator) leads to the 
activation of a MAPK. Within this project we will study further mechanisms of 
activation of MAPKKK and  the specific ind ividual or family contribution to the 
activation of effectors in cellular cond itions where the MAPK axis is implicated . 
We have developed  MEKK-MAPKKK-derived  constructs and  we have found  that 
two MEKK1 constructs reduced  the level of phosphorylated  activated  JNK in 
COS-7 cells. We are developing a panel of miRNA plasmids for most o f MAPKKK 
and  for its d ownstream targets MAPKK. These tools will be used  in models of 
neurodegeneration, excitotoxic neuronal death, development, cancer and  
migration. As results of our project we anticipate a better understand ing on the 
activation of MAPKKK and  its ind ividual-family role in specific cellular 
conditions. As several MAPK- based  therapeutic strategies have failed  because of 
lack of specificity, the above outcomes will allow us to develop more specific 
inhibitory compounds as molecular therapeu tics candidates. 
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VEGF-B167 OVEREXPRESSION, CARDIAC HYPERTROPHY AND EXERCISE 
Jenni Huusko[1], Anniina Muhonen[1], Marike Dijkstra[1], Mari Merentie[1], Kari Alitalo[2], 
Hanna Leskinen[1], Seppo Ylä-Herttuala[1] 
[1] Department of Biotechnology and Molecular Medicine, University of Eastern Finland,  
[2] Biomedicum, University of Helsinki. 
Coronary artery d isease remains the lead ing cause of death in the Western World . 
VEGF-B167, the member of vascu lar endothelial growth factor (VEGF) family, has 
shown comprehensive effects in myocard ial metabolism. The aim was to study 
how much exercise and  card iac VEGF-B167 overexpression could  slow down or 
even prevent already physiologically hypertrophic heart from drifting to the 
pathological condition. We compared  wild type and  transgenic mice in their 
correspondence to physiological, pathological and  both of the previously 
mentioned  hypertrophy types. Physiological hypertrophy was induced  with 
voluntary treadmill exercise (4 or 6 weeks) and  pathological hypertroph y with two 
weeks of angiotensin II treatment. The angiogenic and  functional effects were 
analyzed  by ultrasound  and  histological analyses. RT-PCR was used  to analyze 
mRNA levels of hypertrophy markers and  VEGFs. The hypertrophy markers 
responded  as expected  while VEGF-A levels remained  unchanged . We saw that 
heart function decreased  in transgenic mice with pathological hypertrophy 
compared  to wild type mice. However, the wild type mice had  more fibrosis. The 
role of VEGF-B167 will be clarified  in the future by studying VEGF-B KO animals.
 
 
EVALUATION OF FUNCTIONAL DEFICIT AND RECOVERY IN THE RAT 
SOMATOSENSORY CORTEX AFTER MODERATE TRAUMATIC BRAIN 
INJURY USING FMRI 
Juha-Pekka Niskanen[1,2], Antti Airaksinen[1], Jari Nissinen[1], Asla Pitkänen[1], Olli Gröhn[1] 
[1] Department of Neurobiology, A. I. Virtanen Institute, University of Eastern Finland,  
[2] Department of Physics and Mathematics, University of Eastern Finland. 
Traumatic brain injury (TBI) is a major cause of death and  d isability world wid e. 
Impact to the head  causes immediate d amage and  launches complex cascade of 
second ary injury and  recovery processes. The aim of this study was to evaluate the 
lost of function and  potential recovery in the periphery of the lesion in primary 
somatosensory cortex after moderate TBI using functional magnetic resonance 
imaging (fMRI). Sprague-Dawley rats w ith moderate TBI (n=10) and  sham 
operated  controls (n=6) were imaged  with a 4.7 T MRI scanner during electrical 
stimulation of the forepaws before TBI and  1, 2 and  8 weeks after TBI. A separate 
study using simultaneous local field  potential and  fMRI was conducted  to 
investigate the neuronal coupling of the fMRI response. Ipsilateral somatasensory 
cortex appeared  normal in structural T2-wt MRI. However, response to forepaw 
stimulation was lost after TBI in trauma animals but was maintained  in the 
contralateral side and  in controls. Partial recovery in some of the animals was 
detected  8 weeks after induction of TBI. Furthermore, simultaneous 
electrophysiological record ings and  fMRI confirmed  that the observed  
hemodynamical changes were of neuronal origin. The results suggest that fMRI 
could  serve as non-invasive tool to evaluate functional recovery after TBI. 
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IMPACT OF A-BETA CONFORMERS ON HIPPOCAMPAL AND CORTICAL 
CELL ACTIVITY 
Dorota Kaminska[1], Lívia Fülöp[2], Botond Penke[2], Michael Courtney[1] 
[1] Department of Neurobiology, A.I. Virtanen Institute for Molecular Medicine, University of Eastern Finland, 
[2] University of Szeged. 
	  	 !"#	 	 	 neurodegenerative d isorder characterized  by an 
accumulation of amyloid  plaques, neurofibrillary tangles and  synaptic failure that 
leads to progressive memory loss. A growing body of evidence suggest that the 
longer 42 aa residue form of the amyloid  beta-protein (A-beta), p lays a crucial role 
in AD pathogenesis. A-beta can exist as a monomer, a variety of oligomeric forms 
and  in fibrillar polymers. Recent find ings suggest that soluble oligomeric or 
protofibrillar species may be responsible for impairment of neuronal function. We 
investigate the impact of defined  A-beta species on cell and  synaptic activity in 
both primary hippocampal and  cortical cultures and  the mechanisms responsible 
for this modulation. Signalling under basal conditions and  in response to synaptic 
activity are examined  by measurement of cytoplasmic free calcium, and  activation 
of small G protein and  protein kinase pathways. These are monitored  by 
combinations of fluorescence imaging for single cells record ings and  
immunoblotting for whole cell population responses. Both oligomeric and  
protofibrillar A-beta conformers were prepared . We observe selective increase in 
cytoplasmic free calcium and  calcium sp iking in response to protofibrillar but not 
oligomeric A-beta. 
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NITRO-FATTY ACIDS ACITVATE NRF2 BY KEAP1 CYSTEINE 151-
INDEPENDENT MECHANISM 
Emilia Kansanen[1], Gustavo Bonacci[2], Henna-Kaisa Jyrkkänen[1], Francisco J. Schopfer[2], 
Steven R. Woodcock[2], Seppo Ylä-Herttuala[1], Bruce Freeman[2], Anna-Liisa Levonen[1] 
[1] Department of Biotechnology and Molecular Medicine, University of Eastern Finland,  
[2] Department of Pharmacology & Chemical Biology, University of Pittsburgh. 
Nitro-fatty acids (nitro-FAs) are electrophilic signaling mediators formed via NO-
dependent reactions. Transcriptional profiling of human end othelial cells 
responses to nitro-OA revealed  that nitro-OA activates two d istinct pathways, one 
being activation of the transcription factor Nr f2 and  the other involving HSF-
mediated  transcription. We now report the molecular mechanisms by which nitro -
FAs activate Nrf2 signaling, focusing on the hypothesis that post -translational 
modification of Keap1 cysteines occurs by Michael ad d ition of nitro -FAs to Keap1, 
and  that this event is a significant component of Nrf2 activation and  
card iovascular signaling by nitro-FAs. We identified  the most nitro-OA-reactive 
Keap1 cysteines by mass spectrometry and  found  that nitro-OA adducts C38, 
C226, C257, C273, C288 and  C489.  In add ition, we show that nitro-OA binds to 
Keap1 at nanomolar concentrations in a cellular milieu. Notably, the mutation of 
the highly-reactive C151 of Keap1 d id  not affect nitro-OA bind ing. We also 
utilized  reporter gene expression analysis to reveal the functional role of Keap1 
>J>	  	  	 ?	 	 	 	 	 @-reactive electrophiles, nitro-
OA activated  Nrf2 independent of Keap1 C151. Keap1 is a critical molecu lar target 
for nitro-FAs in Nrf2 activation. Moreover, Keap 1 C151-independent activation of 
Nrf2 contributes to the protective effects of nitro-FAs in the vasculature. 
 
ANTIOXIDANT RESPONSE ELEMENT  REGULATED VECTORS FOR 
CANCER GENE THERAPY 
Hanna Leinonen, Seppo Ylä-Herttuala, Anna-Liisa Levonen 
Department of Biotechnology and Molecular Medicine, University of Eastern Finland. 
Nuclear factor E2-related  factor 2 (Nrf2) is a transcription factor regu lating the 
expression of detoxifying enzymes and  other cytoprotective genes via bind ing to 
the antioxidant response element (ARE). Several d rug-resistant cancer cell lines 
have high constitutive Nrf2 activity due to mutations in Nrf2 or its inhibitor 
Keap1. Moreover, certain anticancer d rugs activate Nrf2. The aim of this stud y 
was therefore to examine whether these at tributes could  be exploited  for cancer 
gene therapy. To this end , we chose to study two cancer cell lines, non -small lung 
cancer A549 cells with constitutively high Nrf2 activity, and  human breast 
carcinoma MCF-7 cells, in which ARE can be activated  by chemotherapeutic 
d rugs. Using lentiviral ARE-luciferase reporter constructs we found  that in A549 
cells, constitutive ARE activity is high and  cannot be further increased  by Nrf2 
inducing agents, whereas MCF-7 cells have a low basal activity ind ucible up to 4.7 
fold  by Nrf2 inducing agents such as d iethylmaleate and  an anticancer d rug 
carmustine. We next examined  whether high ARE activity in A549 cells is 
sufficient to d rive thymid ine kinase (TK) gene for TK-ganciclovir (GCV) suicid e 
gene therapy approach. A549 cells transduced  with lentiviral ARE-TK construct 
had  up to 70% reduced  viability assessed  by MTT assay upon treatment with 
increasing concentrations of GCV. We conclude that ARE-regulated  vectors are 
promising novel tools for cancer gene therapy especia lly in cells with high 
constitutive Nrf2 activity. 
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SUR1-E1506K KNOCK-OUT MOUSE: A DISEASE MODEL FOR IMPAIRED 
INSULIN SECRETION AND TYPE 2 DIABETES 
Maija Tusa[1,2], Jagadish Vangipurapu[1], Teemu Kuulasmaa[1], Jussi Paananen[1], Jarkko 
Ustinov[3], Timo Otonkoski[3], Franz Schuit[4], Frances Ashcroft[5], Leena Alhonen[2], Markku 
Laakso[1] 
[1] Dept of Int Med, [2] Dept of Biot & Mol Med, UEF, [3] Haartman Institute, University of Helsinki, [4] Dept 
of Mol Cell Bio, Katholieke Universiteit Leuven, [5] Dept of Phys, Anat and Genet University of Oxford. 
The objective was to identify the mechanism causing decreased  insu lin secretion 
and  type 2 d iabetes in the patients w ith a point mutation E1506K in the 
sulfonylurea receptor 1 (SUR1) gene. Although hyperinsulinemic in infancy, the 
mutation carriers paradoxically develop insulin d eficiency in ad ulthood . To 
address how the mutation pred isposes to d iabetes, we acquired  a transgenic 
knock-in mouse carrying the Sur1-E1506K mutation. We stud ied  the glucose 
metabolism, islet morphology, SUR1 protein levels, and  performed gene mRNA 
expression arrays on liver, islets and  beta-cells. Insulin secretion and  intracellular 
calcium responses were measured  in vitro. The knock-in mice had  abnormal 
glucose metabolic phenotype, very similar to the adult human SUR1-E1506K 
carriers. Morphologically the Sur1-E1506K mice had  normal islets; Unlike 
previously hypothesized , there was no apoptosis. Thus, the insulin secretion 
deficiency was caused  by a functional defect. In vitro stud ies revealed  abnormal 
islet calcium and  insulin secretion responses to secretagogues. The gene 
expression pattern of the beta cells was intricately altered . The next challenge is to 
pinpoint the detailed  molecular mechanism behind  the hypoinsulinemic 
phenotype of the Sur1-E1506K mice. 
 
CHARACTERIZATION OF AP2-SSAT MOUSE LINE 
Taina Roiha[1], Eija Pirinen[1], Anne Uimari[1], Susanna Vuohelainen[1], Sini Pirnes-Karhu[1], 
Markku Laakso[2], Leena Alhonen[1] 
[1] A.I. Virtanen Institute for Molecular Sciences, Biotechnology and Molecular Medicine, 
[2] Department of Medicine, Biocenter Kuopio, University of Eastern Finland, Kuopio, Finland. 
Previous stud ies with transgenic mice having whole-body overexpression of the 
key enzyme in polyamine catabolism, spermid ine/ spermine N1-acetyltransferase 
(SSAT), have shown that enhanced  polyamine metabolism regulates glucose and  
energy metabolism. The aim of this study is to specify the consequences of 
enhanced  polyamine catabolism to glucose and  energy metabolism in white 
ad ipose tissue (WAT). Therefore we have generated  a transgenic mouse line (aP2-
SSAT mice) overexpressing spermid ine/ spermine-N1-acetyltransferase under an 
ad ipose tissue specific promoter. Our results showed that, in comparison with 
wild -type mice, aP2-SSAT mice had  significantly reduced  WAT mass and  the 
white ad ipocytes had  increased  amount of mitochond ria. In add ition, their oxygen 
consumption was significantly higher revealing that their energy expenditure is 
enhanced . These find ings were explained  by increased  express ion of the key 
regulator of mitochondrial biogenesis and  energy metabolism, peroxisome 
proliferator-activated  recep tor gamma co-activator 1 alpha (PGC-1 a), in WAT of 
aP2-SSAT mice. Based  on glucose and  insulin tolerance tests, no changes in 
glucose metabolism were observed . When challenged  with high-fat d iet (HFD), 
aP2-SSAT mice were resistant to HFD-induced  body weight gain. The results of 
this study suggest that enhanced  polyamine catabolism is an important regulator 
of energy metabolism in WAT. Therefore, this stud y may help to develop novel 
therapeu tic applications for the treatment of obesity and  type 2 d iabetes.  
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SIRT1 REGULATES TCF7L2 IN PANCREATIC BETA-CELLS AND 
ADIPOCYTES 
Shalem Raju Modi[1], Nagendra Kumar Yaluri[1], Antero Salminen[2], Markku Laakso[1] 
[1] Department of Medicine, University of Eastern Finland, Finland, [2] Department of Neurology, University of 
Eastern Finland, Finland. 
Type 2 d iabetes is characterized  by insulin resistance and  impaired  insulin 
secretion. Among 20 susceptibility loci, variants of the transcription factor 7 -like 2 
gene (TCF7L2) have been found  to have the strongest association with the risk of 
type 2 d iabetes. TCF7L2 plays a key role in insulin secretion and  Wnt signaling. 
We tested  whether insulin secretion requires energy and  therefore SIRT1, a histone 
deacetylase and  a master regulator of energy balance could  be involved  in the 
regulation of TCF7L2 function. We investigated  the interaction of TCF7L2 and  
SIRT1 in pancreatic beta-cells and  ad ipocytes. Treatment w ith resveratrol 
enhanced  both TCF7L2 and  SIRT1 protein levels by 1.6 fold  in MIN6 beta-cells. In 
contrast, resveratrol d id  not alter protein levels of AMPK, another key regulator of 
cellular energy status and  metabolism. Resveratrol, a known SIRT1 activator, 
significantly stimulated  insulin secretion in beta -cells in the absence of glucose. In 
ad ipocytes (3T3L1 cells) resveratrol induced  a significant down -regulation of 
TCF7L2 by 5 -fold  in contrast to our find ings in beta-cells. Resveratrol increased  
SIRT1 and  phospho-AMPK protein expression in 3T3L1 cells. Our results suggest 
that there is a tissue specific regulation of TCF7L2 by SIRT1 activation. In beta -
cells TCF7L2 and  SIRT1 interaction may involve a cross- talk between GLP-1 
mediated  Wnt signaling and  insu lin signaling. The mechanisms why and  how 
SIRT1 activation d ownregulates TCF7L2 in ad ipocytes remains to be elucid ated .  
 
ASSOCIATION OF 16 SNPS INCREASING FASTING GLUCOSE LEVEL 
WITH INDICES OF INSULIN RELEASE, PROINSULIN CONVERSION AND 
INSULIN SENSITIVITY IN 6 696 NON-DIABETIC FINNISH MEN   
Alena Stanáková[1], Jagadish Vangipurapu[1], Anne Jackson[2], Lori Bonnycastle[3], Mario 
Morken[3], Jussi Paananen[1], Francis Collins[3], Michael Boehnke[2], Johanna Kuusisto[1], 
Markku Laakso[1] 
[1] Department of Medicine, University of Eastern Finland, Finland, [2] Department of Biostatistics, University 
of Michigan, USA [3] National Human Genome Research Institute, USA . 
We investigated  the effects of 16 loci influencing fasting glucose (FG) level on 
insu lin secretion, conversion of proinsulin to insu lin, and  insu lin sensitivity, in 
order to find  out the mechanisms whereby they affect FG levels. A total of 6,696 
non-d iabetic men (age 57±7 years, BMI 26.8±3.8 kg/ m2) from a large population -
based  cohort were examined . Oral glucose tolerance test (OGTT) and  genotyping 
of SNPs in/ near TCF7L2, SLC30A8, MTNR1B, ADRA2A, FAM148A, CRY2, 
ADCY5, SLC2A2, FADS1, DGKB, PROX1, GCK, G6PC2, GLIS3, GCKR, and  
MADD were performed.Six SNPs were significantly (TCF7L2, SLC30A8, 
MTNR1B) (P<0.001) or nominally (CRY2, FADS1, GCK) (P<0.05) associated  with 
early-phase insulin release (InsAUC0-30/ GluAUC0-30). Seven SNPs were 
significantly (MADD, SLC30A8, TCF7L2, MTNR1B) or nominally (ADCY5, GCKR, 
G6PC2) associated  with ind ices of proinsulin conversion. Only GCKR was 
nominally associated  with insulin sensitivity (Matsuda ISI). Most of the 16 loci 
influencing FG levels were associated  with early-phase insulin release and / or 
ind ices of proinsulin-to-insulin conversion, whereas only one locus was associated  
with insu lin sensitivity. These results give evidence that impaired  insulin secretion 
and  proinsulin processing are important regu lators of FG levels. 
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BIODISTRIBUTION OF IGF-1 IN TRANSGENIC CLN MICE  A NOVEL 
CANDIDATE FOR THE TREATMENT OF INCL 
Tuulia Huhtala[1], Raili Riikonen[2], Anu Jalanko[3], Ale Närvänen[1]. 
[1] University of Eastern Finland, A.I. Virtanen Institute, Kuopio, [2] Kuopio University Hospital, Department 
of Paediatrics, Kuopio, [3] National Institute for Health and Welfare, Public Health Genomics Unit, Helsinki. 
Infantile Neuronal Ceroid  Lipofuscinoses (INCL) is a recessive autosomal genetic 
trait. The d isorder is p rogressive, degenerative, fatal and  extremely rare 
world wide but relatively common in Finlan d . The development of child ren starts 
to regress after 8  18 months and  the average lifespan is 9  11 years. Treatment is 
limited , focused  mainly to relieve the symptoms. It has been shown that low 
concentration of insulin-like growth factor (IGF) 1 in cerebrospinal fluid  is linked  
with pathogenesis in autism at an early age. In previous study with Mnd/ mnd 
animal model it has been shown that only one week treatment with IGF-1 partially 
restored  interneuronal number and  reduced  hypertrophy in subhippocampa l 
subregions. In this stud y the accumulation of I-125 labeled  IGF-1 and  IGF-1-
bind ing protein complex (IGF-BP-3) to the brains was stud ied  in transgenic CLN 
mouse model with SPECT. BP-3 was used  as a control. Our results showed that the 
accumulation of IGF-1 to the brains was 43 % and  IGF-BP-3 14 % higher than 
control 20 min after an i.v. injection. After 2 h the accumulation of IGF-BP-3 was 39 
% higher than control. These results show that IGF-1 accumulates to the brains 
and  it may offer med ical remedy to extremely problematic d isease. These results 
are beneficial base for fu rther stud ies concerning more accurate research of 
kinetics and  dose intermediates to IGF-1 and  IGF-BP-3 before treatment stud ies. 
 
BIOFUNCTIONALIZATION OF MESOPOROUS SILICON 
NANOPARTICLES FOR TARGETED PEPTIDE DELIVERY  
Jussi Rytkönen[1], Vesa-Pekka Lehto[2], Ermei Mäkilä [3], Jarno Salonen [3], Ale Närvänen [1] 
[1] Department of Biotechnology and Molecular Medicine University of Eastern Finland,  
[2] Department of Physics, University of Eastern Finland, [3] Department of Physics, University of Turku. 
We have stud ied  d ispersivity, opsonisation, peptide hormone (IGF-1) release and  
targeting properties of thermally hydrocarbonized  porous silicon nanoparticles 
derivatized  with undecylic acid  (UnTHCPSi). They are negatively charged , 
relative hydrophobic particles, which are hard  to suspense in physiological buffers 
due to agglomeration. We have modulated  the d ispersivity of the nanoparticles 
with d ifferent size (5, 10 and  20 kDa) of polyethylene glycols (PEG) using either 
covalently conjugated  C-PEG or adsorbed  oleic acid -PEG (O-PEG). When 
immersed  in human plasma, the size of the O-PEG-particles increased  less than the 
size of C-PEG or the original particles suggesting the lowest opsonisation degree. 
After the load ing with the peptide, O-PEG removed  weakly adsorbed  IGF-1 from 
the surface and  p lugged  the rest of the pores of the nanoparticles. When incubated  
in human plasma majority of the pep tide hormone is released  from the pores 
within the first hour. Our particles provide good  platform for the development of 
targeted  nanoparticles w ith low opsonisation and  mod ulated  release o f 
hydrophilic peptide hormones. 
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ROLE OF NF-KAPPA-B P50 GENE ON BEHAVIOUR AND 
NEUROPATHOLOGY OF APP/PS1 TRANSGENIC MOUSE MODEL OF AD 
Lakshman Puli, Katja Kanninen, Heikki Tanila, Jari Koistinaho, Tarja Malm 
A. I. Virtanen Institute, University of Eastern Finland, Kuopio. 
Transcription factor nuclear factor kappa-B (NFkB) plays a prominent role in 
	  	 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inflammatory d isease associated  with glial cell activation. NFkB immunoreactivity 
has been found  around  the beta-amyloid  (A-beta) deposits in AD brains. To 
investigate further the role of NFkB in AD pathology progression, we have crossed  
APP/ PS1 transgenic mice with NFkB knockout mice and  established  a mouse line 
carrying mutated  APP and  PS1 transgenes on NFkB p50 nu ll background  to see 
the impact of p50 gene knock-out on behavioral alternations and  A-beta related  
neuropathology in APP/ PS1 mice. The mice were taken through a battery of 
behavioral tests for neophobia, spontaneous activity, motor coord ination, anxiety 
and  spatial memory at the age of 12 months before collecting their brains for 
biochemical and  histological evaluations. APP/ PS1 x p50-knock-out mice 
exhibited  a robust behavioral phenotype. They had  better motor coord ination and  
less anxiety when compared  to their littermate controls. APP/ PS1 transgenic mice 
were impaired  in spatial memory and  possession of p50- knock-out d id  not rescue 
the memory deficits. Histopathology revealed  no d ifferences with respect to A -
beta load  or associated  microglial activation. To conclude, NFkB p50 null 
background  does not affect A-beta plaque pathology or spatial memory deficits in 
APP/ PS1 mice. Whether there are changes in the local inflammatory milieu  
surrounding the A-beta p laques remains to be investigated . 
 
NEUROINFLAMMATION - STEM CELL DERIVED NEURAL PROGENITORS 
AND INFLAMMATORY RESPONSE IN A MOUSE MODEL OF CEREBRAL 
STROKE 
Savolainen Kaisa[1], Puttonen Katja[1], Marika Ruponen[1], Tarja Malm[1], Jonna Koponen[2], 
Seppo Ylä-Herttuala[2], Jari Koistinaho[1], Outi Hovatta [1,3], Anu Muona [1,4] 
[1] Dept of Neurobiology, [2] Dept of Biotech & Mol Med, UEF, Kuopio, [3] Dept for Clinical Science, 
Intervention and Technology, Karolinska Institute, Stockholm, [4] Medeia Therapeutics Ltd, Kuopio, Finland. 
Cerebral stroke is the third  lead ing cause of death world wide and  the current 
treatment is restricted  to the tPA-therapy in 3 hour wind ow and  rehabilitation 
afterwards. Human embryonic pluripotent stem cells (hESC) are able to d ivide 
indefinitely and  d ifferentiate into any kind  of cells. Stud ies have show n that 
transplanted  ESC-derived  neural progenitor cells (NPCs) survive and  enhance 
functional recovery in animals with cerebral stroke. It has been suggested  that 
modulation of inflammation is mostly behind  the beneficial outcome. We 
transplanted  200 000 hESC-derived , either ultra small superparamagnetic iron -
oxide (USPIO) or green fluorescent protein (GFP)-labeled  NPCs into the striatum 
of middle cerebral artery occluded  Balb/ c mice. MRI showed that USPIO -labeled  
NPCs migrated  towards the ischemic site in stroke animals. 12 wks after 
transplantation, tape test revealed  a slight recovery (p=0.059) in treated  vs. 
untreated  animals. In our p revious stud ies immunohistochemistry has shown that 
the transplanted  cells have been positive for neuronal markers and  su rrounding 
cells have been mostly positive for astrocyte and  panhematopoietic markers 
ind icating that they are endogenous. Next we will analyze the inflammation 
associated  factors more thoroughly.  
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NOVEL BENEFICIAL PROPERTIES OF GRANULOCYTE COLONY 
STIMULATING FACTOR TREATMENT IN MOUSE MODEL OF 
AMYOTROPHIC LATERAL SCLEROSIS  
Eveliina Pollari, Nikolay Naumenko, Johanna Magga, Tarja Malm, Rashid Giniatullin, Jari 
Koistinaho 
Neurobiology unit, A . I. Virtanen Institute for Molecular Medicine, University of Eastern Finland. 
Amyotrophic lateral sclerosis (ALS) is a lethal, incurable and  progressive 
neurodegenerative d isease with d istinctive features includ ing loss of motor 
neurons, denervation of target muscles, muscle atrophy and  paralysis. Our data 
suggest that granulocyte colony stimulating factor (GCSF), a neuroprotective 
agent, has beneficial effects on transgenic G93A-SOD1 mice, a d isease model of 
ALS. We assessed  GCSF mediated  protection to CNS, peripheral hematopoietic 
system and  neuromuscular junction activity. In this study setup G93A-SOD1 mice 
and  wild -type mice received  weekly GCSF injections (0,3 mg/ kg) starting at pre -
symptomatic stage. Treatment prolonged  survival of male transgenic mice. Effect 
of GCSF on motoneuron survival in spinal cord  will be assessed  at end -stage of 
d isease from histological samples. Properties of neuromuscular junction were 
measured  from d iaphragm at symptomatic stage. In comparison to age-matched  
wild -type mice, G93A-SOD1 mice d isplayed  decline in several characteristics of 
neuromuscular transmission and  in transgenic mice GCSF treatment significantly 
improved  all these functions. These results further validate beneficial properties of 
GCSF as a neuroprotective factor and  suggest this neurotrophin for the treatment 
of ALS. 
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PDI REGULATES SOD1 ACTIVITY AND CONTROLS CYTOCHROME C-
CATALYZED PEROXIDATION  IMPLICATIONS FOR MITOCHONDRIAL 
ROS PRODUCTION IN ALS MODELS 
Merja Jaronen[1], Toni Ahtoniemi[2], Jari Koistinaho[1] and Gundars Goldsteins[1] 
[1] A. I. Virtanen Institute for Molecular Sciences, UEF [2] Medeia Therapeutics Ltd, Kuopio, Finland. 
We have demonstrated  that in G93A-SOD1 rats the mutant superoxide d ismutase 
1 (SOD1) is up regulated  in the intermembrane space (IMS) and  possess increased  
ability to bind  the inner membrane of isolated  mitoplasts. In parallel, protein 
d isulfide isomerase (PDI) expression peaks in the spinal cord  of G93A -SOD1 in rat 
and  mouse models at presymptomatic stage of the d isease. These find ings allow 
us to hypothesize that increased  PDI expression may lead  to the aberrant control 
of SOD1 activity in the mitochondrial IMS and  may cause increased  
hydroperoxide production in this compartment, eventually resulting in neuronal 
vulnerability. Our aim was to investigate whether PDI can exercise redox control 
of SOD1 activity lead ing to increased  hydroperoxide production and  cytochrome 
c-catalysed  peroxid ation in vitro and  HEK-293 cell cu lture. Our results show that 
PDI catalyzes reactivation of SOD1 after inactivation by d isu lphide bond 
reduction. This reactivation resulted  in increased  hydroperoxide production and  
cytochrome c-catalysed  peroxidation. Both reactivation and  increased  
peroxidation were inhibited  by bacitracin, a PDI inhibitor. Inhibition of PDI by 
bacitracin suppressed  also paraquat-induced  hydroperoxide production in HEK-
293 cells. These results elucidate the possible role of PDI in controlling SOD1 
activity within the IMS and  its impact on mitochond rial ROS production in ALS 
models. 
 
CHARACTERIZATION OF THE PHAGOCYTIC CAPACITY OF BONE 
MARROW DERIVED MONOCYTIC CELLS TOWARDS A-BETA 
Ekaterina Savchenko[1], Johanna Magga[1], Tarja Malm[1], Anu Muona[2], Milla Koistinaho[2], 
Jari Koistinaho[1] 
[1] A.I. Virtanen Institute for Molecular Sciences, UEF, [2] Medeia Therapeutics Ltd., Kuopio, Finland. 
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age-dependent and  progressive accumulation of beta -amyloid  (AB) plaques. An 
imbalance between prod uction and  clearance of toxic AB peptides causes 
abnormal accumulation and  eventually resu lts in cell death. Monocytic cells 
derived  from bone marrow (BM) have been shown actively participate in the 
reduction of AB burden but the reasons for insufficient clearance are still 
unknown. The aim was to investigate the phagocytic capacity of BM -derived  
monocytic cells towards AB depending on the d ifferent way of their isolation. In 
d irect way, CD11b monocytes were isolated  from mouse BM by positive and  
negative selection whereas ind irect way included  proliferation and  d ifferentiation 
of monocytic cells from BM hematopoietic stem cells. The phagocytic capacity of 
monocytic cells was assessed  in ex vivo assays in which the cells were plat ed  on 
hippocampal brain sections prepared  from aged  APP/ PS1 mice. Our results show 
that monocytic cells obtained  both d irectly from BM and  d ifferentiated  from BM 
stem cells were able to degrade AB. Moreover, CD11b monocytes isolated  by 
negative selection d egraded  AB more efficiently than CD11b monocytes isolated  
by positive selection. Prolonged  proliferation of stem cells d id  not reduce cells 
phagocytic capacity but led  to generation of monocytic cells with increased  
phagocytic ability toward s AB. 
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ORGANOTYPIC SLICE CULTURE IN SPINAL CORD INJURY 
Susanna Boman[1], Katja Puttonen[1], Marika Ruponen[1], Tarja Malm[1], Outi Hovatta[2], Jari 
Koistinaho[1] 
[1] A.I Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland,  
[2] Department for Clinical Science, Intervention and Technology, Division of Obstetrics and Gynecology, 
Karolinska Institute, Stockholm, Sweden. 
Spinal cord  injury (SCI) is a devastating event lead ing to serious long lasting 
consequences. Due to limited  recovery and  medical treatment after SCI, cell 
replacement therapy has become a promising therapeutic research area. Although 
primary and  secondary injury mechanisms have been stud ied  in many in vivo 
models, the in vitro organotypic slice cultures offer an opportunity to investigate 
both intra- and  extracellular pathophysiological mechanisms in live 
cytoarchitecture after injury. The purpose of this study was to set up  an in vitro 
model of SCI and  study the migration and  d ifferentiation of human embryonic 
derived  neuronal progenitor cells (NPC) injected  into slices after in vitro trauma. 
Lentivirally transduced  NPCs expressing green fluorescent protein (GFP) were 
injected  into the intact and  injured  slices and  their migration and  maturation was 
determined  microscopically. Preliminary find ings suggest that NPCs cultivated 
more 5 d ays in neural induction medium without fibroblast growth factor 
d ifferentiated  into neuronal cells. Neuronal projections were seen in one week 
after injection to slices and  persisted  at least up to five weeks. NPCs migrated  
inside the slices. Our find ings ind icate that NPCs survive and  have capacity to 
migrate and  possibly maturate into neuronal cells on organotypic slice cultures. 
This model proved  to be a potential method  for research  of cell rep lacement after 
SCI. 
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